Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases Mary-Ann FitzcharlesWinfried Häuser Complementary and Alternative Medicine (S Kolasinski, Section Editor) 10 November 2016 Article: 76
Imaging in Juvenile Spondyloarthritis Pamela F. WeissNancy A. ChauvinJohannes Roth Spondyloarthritis (M Khan, Section Editor) 07 November 2016 Article: 75
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature Virginie DufrostJessie RisseDenis Wahl Antiphospholipid Syndrome (S Zuily, Section Editor) 03 November 2016 Article: 74
Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years Zachary OaksThomas WinansAndras Perl Systemic Lupus Erythematosus (G Tsokos, Section Editor) 03 November 2016 Article: 73
Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis Zheni StavreKatherine UpchurchEllen M. Gravallese Spondyloarthritis (M Khan, Section Editor) 03 November 2016 Article: 72
Monogenic Lupus Mindy S. Lo Systemic Lupus Erythematosus (G Tsokos, Section Editor) 03 November 2016 Article: 71
Predictors of Poor Outcome in ANCA-Associated Vasculitis (AAV) Luis E. VegaLuis R. Espinoza Vasculitis (L Espinoza, Section Editor) 03 November 2016 Article: 70